Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy.
Shamji MH, Larson D, Eifan A, Scadding GW, Qin T, Lawson K, Sever ML, Macfarlane E, Layhadi JA, Würtzen PA, Parkin RV, Sanda S, Harris KM, Nepom GT, Togias A, Durham SR. Shamji MH, et al. Among authors: parkin rv. J Allergy Clin Immunol. 2021 Oct;148(4):1061-1071.e11. doi: 10.1016/j.jaci.2021.03.030. Epub 2021 Apr 2. J Allergy Clin Immunol. 2021. PMID: 33819508 Free article. Clinical Trial.
Role of IL-35 in sublingual allergen immunotherapy.
Shamji MH, Layhadi JA, Achkova D, Kouser L, Perera-Webb A, Couto-Francisco NC, Parkin RV, Matsuoka T, Scadding G, Ashton-Rickardt PG, Durham SR. Shamji MH, et al. Among authors: parkin rv. J Allergy Clin Immunol. 2019 Mar;143(3):1131-1142.e4. doi: 10.1016/j.jaci.2018.06.041. Epub 2018 Jul 25. J Allergy Clin Immunol. 2019. PMID: 30053528 Free article.
Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial.
Sharif H, Singh I, Kouser L, Mösges R, Bonny MA, Karamani A, Parkin RV, Bovy N, Kishore U, Robb A, Katotomichelakis M, Holtappels G, Derycke L, Corazza F, von Frenckell R, Wathelet N, Duchateau J, Legon T, Pirotton S, Durham SR, Bachert C, Shamji MH. Sharif H, et al. Among authors: parkin rv. J Allergy Clin Immunol. 2019 Sep;144(3):738-749. doi: 10.1016/j.jaci.2019.02.023. Epub 2019 Mar 5. J Allergy Clin Immunol. 2019. PMID: 30844425 Free article. Clinical Trial.
Intralymphatic immunotherapy in pollen-allergic young adults with rhinoconjunctivitis and mild asthma: A randomized trial.
Konradsen JR, Grundström J, Hellkvist L, Tran TAT, Andersson N, Gafvelin G, Kiewiet MBG, Hamsten C, Tang J, Parkin RV, Shamji MH, Hedlin G, Cardell LO, van Hage M. Konradsen JR, et al. Among authors: parkin rv. J Allergy Clin Immunol. 2020 Mar;145(3):1005-1007.e7. doi: 10.1016/j.jaci.2019.11.017. Epub 2019 Nov 24. J Allergy Clin Immunol. 2020. PMID: 31775016 Clinical Trial. No abstract available.
Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy.
Sharif H, Acharya S, Dhondalay GKR, Varricchi G, Krasner-Macleod S, Laisuan W, Switzer A, Lenormand M, Kashe E, Parkin RV, Yi Y, Koc M, Fedina O, Vilà-Nadal G, Marone G, Eifan A, Scadding GW, Fear DJ, Nadeau KC, Durham SR, Shamji MH. Sharif H, et al. Among authors: parkin rv. J Allergy Clin Immunol. 2021 Feb;147(2):663-676. doi: 10.1016/j.jaci.2020.10.035. Epub 2020 Nov 6. J Allergy Clin Immunol. 2021. PMID: 33160969
Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
Shamji MH, Singh I, Layhadi JA, Ito C, Karamani A, Kouser L, Sharif H, Tang J, Handijiev S, Parkin RV, Durham SR, Kostic A, Orengo JM, DeVeaux M, Kamal M, Stahl N, Yancopoulos GD, Wang CQ, Radin AR. Shamji MH, et al. Among authors: parkin rv. Am J Respir Crit Care Med. 2021 Jul 1;204(1):23-33. doi: 10.1164/rccm.202011-4107OC. Am J Respir Crit Care Med. 2021. PMID: 33651675 Free PMC article. Clinical Trial.
Single-cell RNA sequencing identifies precise tolerogenic cellular and molecular pathways induced by depigmented-polymerized grass pollen allergen extract.
Layhadi JA, Moya R, Tan TJ, Lenormand MM, Sharif H, Parkin RV, Vila-Nadal G, Fedina O, Zhu R, Laisuan W, Durham SR, Carnés J, Shamji MH. Layhadi JA, et al. Among authors: parkin rv. J Allergy Clin Immunol. 2023 May;151(5):1357-1370.e9. doi: 10.1016/j.jaci.2022.11.030. Epub 2023 Jan 14. J Allergy Clin Immunol. 2023. PMID: 36649758 Free article.
Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy.
Altman MC, Segnitz RM, Larson D, Jayavelu ND, Smith MT, Patel S, Scadding GW, Qin T, Sanda S, Steveling E, Eifan AO, Penagos M, Jacobson MR, Parkin RV, Shamji MH, Togias A, Durham SR. Altman MC, et al. Among authors: parkin rv. J Allergy Clin Immunol. 2023 Nov;152(5):1247-1260. doi: 10.1016/j.jaci.2023.06.025. Epub 2023 Jul 15. J Allergy Clin Immunol. 2023. PMID: 37460024 Free PMC article. Clinical Trial.
Nasal allergen-neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis.
Eguiluz-Gracia I, Parkin RV, Layhadi JA, Palmer E, Meng X, Zhu R, Sahiner U, Durham SR, Torres MJ, Mayorga C, Rondon C, Shamji MH. Eguiluz-Gracia I, et al. Among authors: parkin rv. Allergy. 2024 Aug;79(8):2197-2206. doi: 10.1111/all.16083. Epub 2024 Mar 14. Allergy. 2024. PMID: 38483174 Clinical Trial.
11 results